Regeneron Pharmaceuticals (REGN) market cap

Market cap today
$99.08B

Regeneron Pharmaceuticals (REGN) has a market cap of $99.08B. At the end of fiscal 2025 (December 31, 2025) its market cap was $83.83B. That is 2.2% higher than the $81.99B of fiscal 2024. Today's figure is 18.2% above the fiscal 2025 year-end. Figures as of 18 Nov 2026, 11:38 UTC, from the company's filings with the SEC and Yahoo Finance.

Key facts

Market cap today
$99.08B
Market cap, fiscal 2025
$83.83B
Change on fiscal 2024
+2.2%
Growth, 5 years
+8.6% a year
Growth, 10 years
+3.0% a year
Highest on record
$99.86Bfiscal 2023
Lowest on record
$2.72Bfiscal 2010
Fiscal years on record
162010–2025

Figures as of . Older fiscal years come from the company's filings with the SEC, recent ones from Yahoo Finance. Amounts are in USD. Figures, not advice.

Regeneron Pharmaceuticals market cap, in more detail

Over the five fiscal years to 2025 the market cap grew at a compound 8.6% a year; over ten years the rate was 3.0% a year. Across the 16 fiscal year-ends on record (2010–2025), the highest was $99.86B in fiscal 2023 and the lowest $2.72B in fiscal 2010.

History · 16 fiscal years

Market cap at each fiscal year-end

The last point is today's figure; the others are fiscal year-ends.

Regeneron Pharmaceuticals market cap, year by year

Regeneron Pharmaceuticals (REGN) market cap by fiscal year
Fiscal yearMarket capChangeYear endedShare price at year-endDiluted shares
Today$99.08B—$957.76—
2025$83.83B 2.2% up$771.87108.60M
2024$81.99B 17.9% down$712.33115.10M
2023$99.86B 21.9% up$878.29113.70M
2022$81.89B 15.6% up$721.49113.50M
2021$70.86B 27.4% up$631.52112.20M
2020$55.61B 29.2% up$483.11115.10M
2019$43.03B 0.4% up$375.48114.60M
2018$42.88B 1.6% down$373.50114.80M
2017$43.57B 2.1% up$375.96115.90M
2016$42.69B 31.8% down$367.09116.30M
2015$62.55B 34.4% up$542.87115.23M
2014$46.53B 51.9% up$410.25113.41M
2013$30.63B 55.2% up$275.24111.29M
2012$19.74B 293.0% up$171.07115.38M
2011$5.02B 84.5% up$55.4390.61M
2010$2.72B—$32.8382.93M
2009——$24.18—
2008——$18.36—

Change is on the fiscal year before; a dash means that year is not on record or the earlier figure was not positive. A dash anywhere else means the figure was not reported or cannot be computed — it is never filled in.

Method

How it is calculated

Market cap is the share price multiplied by the number of shares: for past years this page multiplies the diluted share count in each annual report by the closing price for the month that fiscal year ended in, and today's figure comes from the live quote.

How to read it

It is what the stock market says the whole company is worth — a measure of size, not of whether the shares are cheap or dear.

Market cap at health care companies of similar size

Market cap of Regeneron Pharmaceuticals and comparable companies
CompanyMarket cap
Moderna MRNA$83.68B
CVS Health CVS$109.79B
HCA Healthcare HCA$104.69B
GSK GSK$98.70B
Regeneron Pharmaceuticals REGN$99.08B
Elevance Health ELV$93.75B

Today's market value as the market data feed reports it, each in the currency its shares trade in.

More on REGN

Regeneron Pharmaceuticals, figure by figure

Regeneron Pharmaceuticals (REGN) overview: price, valuation and scorecardAll health care companies by market value

Regeneron Pharmaceuticals market cap: questions and answers

What is Regeneron Pharmaceuticals's market cap?

Regeneron Pharmaceuticals (REGN) has a market cap of $99.08B. At the end of fiscal 2025 (December 31, 2025) its market cap was $83.83B. That is 2.2% higher than the $81.99B of fiscal 2024.

What is the growth rate of Regeneron Pharmaceuticals's market cap?

Over the five fiscal years to 2025 the market cap grew at a compound 8.6% a year; over ten years the rate was 3.0% a year.

What are the highest and lowest market cap figures on record for Regeneron Pharmaceuticals?

Across the 16 fiscal year-ends on record (2010–2025), the highest was $99.86B in fiscal 2023 and the lowest $2.72B in fiscal 2010.

How is Regeneron Pharmaceuticals's market cap calculated?

Market cap is the share price multiplied by the number of shares: for past years this page multiplies the diluted share count in each annual report by the closing price for the month that fiscal year ended in, and today's figure comes from the live quote. For Regeneron Pharmaceuticals it is on record here for 16 fiscal years, 2010 to 2025.

Share prices are Yahoo Finance's monthly closes: a fiscal year-end is paired with the close of the month it falls in, and today's quote may be delayed. Fiscal years are named for the calendar year they end in.

Cite this page

Funkfolio, “Regeneron Pharmaceuticals (REGN) market cap”, data as of 18 November 2026. https://funkfolio.com/stock/REGN/market-cap

Underlying data: the company's filings with the SEC and Yahoo Finance.